일부 국가의 약제비 본인부담 차등화 제도 유형과 정책적 시사점
Differential Copayment System of Pharmaceutical Expenditure in Belgium, Denmark, Finland and France, and Its Policy Implication
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Pharmaceutical copayment system is widely used worldwide as a measure of pharmaceutical cost con- tainment. But, its disadvantage is known to decrease access to medication especially to essential drug and chronic disease treatment. In Korea, chronic patients might have access problem because of their diseases need life-long expenditure. Differential copayment system according to pharmaceutical- and therapeutical class is a copayment system which alleviate such disadvantage. This article investigate dif- ferential copayment system depending on pharmaceuticals which is administered in Belgium, France, Finland, and Denmark to ensure the access of the chronic patients.
Abstract
Pharmaceutical copayment system is widely used worldwide as a measure of pharmaceutical cost con- tainment. But, its disadvantage is known to decrease access to medication especially to essential drug and chronic disease treatment. In Korea, chronic patients might have access problem because of their diseases need life-long expenditure. Differential copayment system according to pharmaceutical- and therapeutical class is a copayment system which alleviate such disadvantage. This article investigate dif- ferential copayment system depending on pharmaceuticals which is administered in Belgium, France, Finland, and Denmark to ensure the access of the chronic patients.
참고문헌 (21)
- "OECD Health Data 2014"[URL]
- 배은영, "약제비 증가의 기여 요인과 영향 분석", 보건경제와 정책연구, 13(2), pp.39~54 (2007), 한국보건경제정책학회
- Analysis of determinants of pharmaceutical expenditure in NHI, "Jang SM", Health Insurance Review and Assessment Service, ~ (2010)
- Mossialos E, "Regulating Pharmaceuticals in Europe: striving for efficiency, equity and quality" (2004), Open University Press
- Yang BM, "Health Economics (Nanamsinseo 1718)" (2015), Nanam
- Barnieh L, "A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development", PLoS One, 9, pp.e90434~ (2014)
- Goldman DP, "Prescription drug cost sharing: associations with medication and medical utilization and spending and health", JAMA, 298, pp.61~69 (2007)
- Goldman DP, "Pharmacy benefits and the use of drugs by the chronically ill", JAMA, 291, pp.2344~2350 (2004)
- Pharmaceutical policy and health insurance system in 17 countries in 2005, "9)Kim SO", National Health Insurance Service, ~ (2005)
- OECD, "Pharmaceutical Pricing Policies in a Global Market", OECD, ~ (2008)
- 2014-2018 Mid-term Plan for National Health Insurance Reinforcement, "Ministry of Health and Welfare", ~ (2015)
- Health system and reform in Belgium, "Lim SJ", Health Insurance Policy Institute in National Health Insurance Service, ~ (2014)
- Kela, "FINLAND-Recent and planned changes in pharmaceutical pricing and reimbursement and overview of the medical devices system", 16th PPRI Meeting (2014)
- Peura S, "Pharmaceutical Pricing and Reimbursement Information project commissioned by European Commission, Health and Consumer Protection Directorate-General and the Austrian Ministry of Health, Family and Youth", PPRI Pharma profile-FINLAND, ~ (2007)
- Rationalization of pharmaceutical expenditure in NHI, "Huh SI", National Health Insurance Advancement Committee, ~ (2010)
- Health system and reform in France, "Choi KC", Health Insurance Policy Institute in National Health Insurance Service, ~ (2014)
- National Health Insurance Service, "Pharmaceutical policy in foreign countries in 2013", Handbook of the Department of Health Insurance Benefits, ~ (2013)
- Evaluation of outpatient copayment reform, "National Health Insurance Service", Department of Health Insurance Benefits, ~ (2008)
- 변진옥, "요양기관 종별 외래본인부담차등정책의 효과분석", 한국사회정책, 21(2), pp.35~55 (2014), 한국사회정책학회[DOI]
- Report on out-of-pocket expenditure in NHI in 2012, "Seo NK", Health Insurance Policy Institute in National Health Insurance Service, ~ (2013)
- Introduction of differential copayment system of outpatient pharmaceutical expenditure, "Kim SO", Health Insurance Policy Institute in National Health Insurance Service, ~ (2010)